218 related articles for article (PubMed ID: 25193692)
1. Does expression of glucose transporter protein-1 relate to prognosis and angiogenesis in osteosarcoma?
Kubo T; Shimose S; Fujimori J; Furuta T; Arihiro K; Ochi M
Clin Orthop Relat Res; 2015 Jan; 473(1):305-10. PubMed ID: 25193692
[TBL] [Abstract][Full Text] [Related]
2. p16 expression as a prognostic and predictive marker in high-grade localized osteosarcoma of the extremities: an analysis of 357 cases.
Righi A; Gambarotti M; Sbaraglia M; Sisto A; Ferrari S; Dei Tos AP; Picci P
Hum Pathol; 2016 Dec; 58():15-23. PubMed ID: 27544803
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Trps1 contributes to tumor angiogenesis and poor prognosis of human osteosarcoma.
Li Z; Jia M; Wu X; Cui J; Pan A; Li L
Diagn Pathol; 2015 Sep; 10():167. PubMed ID: 26377811
[TBL] [Abstract][Full Text] [Related]
4. Vitronectin significantly influences prognosis in osteosarcoma.
Shi K; Lan RL; Tao X; Wu CY; Hong HF; Lin JH
Int J Clin Exp Pathol; 2015; 8(9):11364-71. PubMed ID: 26617861
[TBL] [Abstract][Full Text] [Related]
5. Elevated Expression of Transforming Acidic Coiled-Coil Containing Protein 3 (TACC3) Is Associated With a Poor Prognosis in Osteosarcoma.
Matsuda K; Miyoshi H; Hiraoka K; Hamada T; Nakashima K; Shiba N; Ohshima K
Clin Orthop Relat Res; 2018 Sep; 476(9):1848-1855. PubMed ID: 30024460
[TBL] [Abstract][Full Text] [Related]
6. Tumor angiogenesis and outcome in osteosarcoma.
Mikulić D; Ilić I; Cepulić M; Orlić D; Giljević JS; Fattorini I; Seiwerth S
Pediatr Hematol Oncol; 2004; 21(7):611-9. PubMed ID: 15626017
[TBL] [Abstract][Full Text] [Related]
7. Lack of prognostic significance of intratumoral angiogenesis in nonmetastatic osteosarcoma.
Mantadakis E; Kim G; Reisch J; McHard K; Maale G; Leavey PJ; Timmons C
J Pediatr Hematol Oncol; 2001; 23(5):286-9. PubMed ID: 11464984
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis.
Kaya M; Wada T; Akatsuka T; Kawaguchi S; Nagoya S; Shindoh M; Higashino F; Mezawa F; Okada F; Ishii S
Clin Cancer Res; 2000 Feb; 6(2):572-7. PubMed ID: 10690541
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2 overexpression predicts poor survival in patients with high-grade extremity osteosarcoma: a pilot study.
Urakawa H; Nishida Y; Naruse T; Nakashima H; Ishiguro N
Clin Orthop Relat Res; 2009 Nov; 467(11):2932-8. PubMed ID: 19326179
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of angiogenesis in nonmuscle invasive bladder cancer as defined by microvessel density after immunohistochemical staining for CD34.
Ajili F; Kacem M; Tounsi H; Darouiche A; Enayfer E; Chebi M; Manai M; Boubaker S
Ultrastruct Pathol; 2012 Oct; 36(5):336-42. PubMed ID: 22574784
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant multidrug chemotherapy including high-dose methotrexate modifies VEGF expression in osteosarcoma: an immunohistochemical analysis.
Rossi B; Schinzari G; Maccauro G; Scaramuzzo L; Signorelli D; Rosa MA; Fabbriciani C; Carlo B
BMC Musculoskelet Disord; 2010 Feb; 11():34. PubMed ID: 20158913
[TBL] [Abstract][Full Text] [Related]
12. The expression of novel gene URG4 in osteosarcoma: correlation with patients' prognosis.
Huang J; Zhu B; Lu L; Lian Z; Wang Y; Yang X; Satiroglu-Tufan NL; Liu J; Luo Z
Pathology; 2009 Feb; 41(2):149-54. PubMed ID: 18972316
[TBL] [Abstract][Full Text] [Related]
13. Association of MMP-2 expression and prognosis in osteosarcoma patients.
Zhang M; Zhang X
Int J Clin Exp Pathol; 2015; 8(11):14965-70. PubMed ID: 26823829
[TBL] [Abstract][Full Text] [Related]
14. Proximal tumor location and fluid-fluid levels on MRI predict resistance to chemotherapy in stage IIB osteosarcoma.
Jeon DG; Song WS; Cho WH; Kong CB; Cho SH
Clin Orthop Relat Res; 2014 Jun; 472(6):1911-20. PubMed ID: 24574120
[TBL] [Abstract][Full Text] [Related]
15. What are the factors that affect survival and relapse after local recurrence of osteosarcoma?
Takeuchi A; Lewis VO; Satcher RL; Moon BS; Lin PP
Clin Orthop Relat Res; 2014 Oct; 472(10):3188-95. PubMed ID: 24980644
[TBL] [Abstract][Full Text] [Related]
16. Interferon-α/β receptor as a prognostic marker in osteosarcoma.
Kubo T; Shimose S; Matsuo T; Fujimori J; Arihiro K; Ochi M
J Bone Joint Surg Am; 2011 Mar; 93(6):519-26. PubMed ID: 21411701
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of HLA EMR8-5 immunohistochemically analyzed expression in osteosarcoma.
Nada OH; Ahmed NS; Abou Gabal HH
Diagn Pathol; 2014 Mar; 9():72. PubMed ID: 24667142
[TBL] [Abstract][Full Text] [Related]
18. Surgical resection of relapse may improve postrelapse survival of patients with localized osteosarcoma.
Wong KC; Lee V; Shing MM; Kumta S
Clin Orthop Relat Res; 2013 Mar; 471(3):814-9. PubMed ID: 22972657
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a pretreatment prognostic index to predict death and lung metastases in extremity osteosarcoma.
Wang B; Tu J; Yin J; Zou C; Wang J; Huang G; Xie X; Shen J
Oncotarget; 2015 Nov; 6(35):38348-59. PubMed ID: 26435480
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant Chemotherapy Followed by Delayed Surgery: Is it Necessary for All Patients With Nonmetastatic High-Grade Pelvic Osteosarcoma?
Xu J; Xie L; Guo W
Clin Orthop Relat Res; 2018 Nov; 476(11):2177-2186. PubMed ID: 29912746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]